The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets.

Carbon nanotubes (CNT) are one of the most promising nanomaterials for use in medicine. The blood biocompatibility of CNT is a critical safety issue. In the bloodstream, proteins bind to CNT through non-covalent interactions to form a protein corona, thereby largely defining the biological properties of the CNT. Here, we characterize the interactions of carboxylated-multiwalled carbon nanotubes (CNTCOOH) with common human proteins and investigate the effect of the different protein coronas on the interaction of CNTCOOH with human blood platelets (PLT). Molecular modeling and different photophysical techniques were employed to characterize the binding of albumin (HSA), fibrinogen (FBG), γ-globulins (IgG) and histone H1 (H1) on CNTCOOH. We found that the identity of protein forming the corona greatly affects the outcome of CNTCOOH's interaction with blood PLT. Bare CNTCOOH-induced PLT aggregation and the release of platelet membrane microparticles (PMP). HSA corona attenuated the PLT aggregating activity of CNTCOOH, while FBG caused the agglomeration of CNTCOOH nanomaterial, thereby diminishing the effect of CNTCOOH on PLT. In contrast, the IgG corona caused PLT fragmentation, and the H1 corona induced a strong PLT aggregation, thus potentiating the release of PMP.

[1]  A. Antczak,et al.  IgG-complex stimulated platelets: a source of sCD40L and RANTES in initiation of inflammatory cascade. , 2010, Cellular immunology.

[2]  Changyou Gao,et al.  Molecular interactions of different size AuNP-COOH nanoparticles with human fibrinogen. , 2013, Nanoscale.

[3]  Hui Hu,et al.  Chemically Functionalized Carbon Nanotubes as Substrates for Neuronal Growth. , 2004, Nano letters.

[4]  M. Gelderman,et al.  Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. , 2009, Nano letters.

[5]  W. Rosse,et al.  Characterization of the IgG-Fc receptor on human platelets. , 1982, Blood.

[6]  A. Y. Chiu,et al.  Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. , 1984, The Journal of clinical investigation.

[7]  K. Popat,et al.  Hemocompatibility of polymeric nanostructured surfaces , 2013, Journal of biomaterials science. Polymer edition.

[8]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[9]  D. Khang,et al.  Conformational changes of fibrinogen in dispersed carbon nanotubes , 2012, International journal of nanomedicine.

[10]  Eva Pebay-Peyroula,et al.  Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. , 2011, ACS nano.

[11]  Y. Akdoğan,et al.  Evidence for Water-Tuned Structural Differences in Proteins: An Approach Emphasizing Variations in Local Hydrophilicity , 2012, PloS one.

[12]  W. Rosse,et al.  Characterization of the IgG-Fc receptor on human platelets , 1982 .

[13]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[14]  R. Gurny,et al.  Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  P. Rouxhet,et al.  Competitive adsorption of fibrinogen and albumin and blood platelet adhesion on surfaces modified with nanoparticles and/or PEO. , 2010, Colloids and surfaces. B, Biointerfaces.

[16]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[18]  S. Orton,et al.  Vesiculation of platelets during in vitro aging. , 1991, Blood.

[19]  W. J. Zhang,et al.  Non-functionalized carbon nanotube binding with hemoglobin. , 2008, Colloids and surfaces. B, Biointerfaces.

[20]  Nunzio Bottini,et al.  Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. , 2013, ACS nano.

[21]  Y. Chiang,et al.  Peptides with selective affinity for carbon nanotubes , 2003, Nature materials.

[22]  Bo Chen,et al.  In vitro evaluation of cytotoxicity and oxidative stress induced by multiwalled carbon nanotubes in murine RAW 264.7 macrophages and human A549 lung cells. , 2011, Biomedical and environmental sciences : BES.

[23]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[24]  J. Luong,et al.  Purification, functionalization, and bioconjugation of carbon nanotubes. , 2011, Methods in molecular biology.

[25]  David Farrar,et al.  Interpretation of protein adsorption: surface-induced conformational changes. , 2005, Journal of the American Chemical Society.

[26]  K. Holada,et al.  Surface Expression of Major Membrane Glycoproteins on Resting and TRAP-Activated Neonatal Platelets , 1996, Pediatric Research.

[27]  T. Xia,et al.  Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. , 2012, Nano letters.

[28]  J. Bonevich,et al.  Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[29]  R. Doolittle,et al.  Crystal structure of human fibrinogen. , 2009, Biochemistry.

[30]  J. Meng,et al.  Carbon nanotubes induce secondary structure changes of bovine albumin in aqueous phase. , 2010, Journal of nanoscience and nanotechnology.

[31]  B. Ratner,et al.  Selective protein adsorption modulates platelet adhesion and activation to oligo(ethylene glycol)-terminated self-assembled monolayers with C18 ligands. , 2009, Journal of biomedical materials research. Part A.

[32]  Anton J Hopfinger,et al.  Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor? , 2009, Molecular pharmaceutics.

[33]  M. Cohen,et al.  Extracellular histone release in response to traumatic injury: Implications for a compensatory role of activated protein C , 2012, The journal of trauma and acute care surgery.

[34]  C. Esmon,et al.  Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. , 2011, Blood.

[35]  S. D. Hudson,et al.  Carbon nanotubes activate store-operated calcium entry in human blood platelets. , 2011, ACS nano.

[36]  Nicole M. Iverson,et al.  In Vivo Biosensing Via Tissue Localizable Near Infrared Fluorescent Single Walled Carbon Nanotubes , 2013, Nature nanotechnology.

[37]  K. Kobayashi,et al.  CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN , 1998 .

[38]  Agnes B Kane,et al.  Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. , 2008, Small.

[39]  R. Zhou,et al.  Binding of blood proteins to carbon nanotubes reduces cytotoxicity , 2011, Proceedings of the National Academy of Sciences.

[40]  T. Vakhrusheva,et al.  Albumin reduces thrombogenic potential of single-walled carbon nanotubes. , 2013, Toxicology letters.

[41]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[42]  V. Gun'ko,et al.  Nuclear Magnetic Resonance Studies of Interfacial Phenomena , 2013 .

[43]  A. Seifalian,et al.  A new era of cancer treatment: carbon nanotubes as drug delivery tools , 2011, International journal of nanomedicine.

[44]  L. Vogler.  Lehninger Principles Of Biochemistry 5th Edition , 2016 .

[45]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[46]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[47]  David F. Williams.  On the mechanisms of biocompatibility. , 2008, Biomaterials.

[48]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[49]  J. Freedman,et al.  Platelets and the immune continuum , 2011, Nature Reviews Immunology.

[50]  H. Takita,et al.  Carbon nanotubes functionalized with fibroblast growth factor accelerate proliferation of bone marrow-derived stromal cells and bone formation , 2013, Nanotechnology.

[51]  Jack F Douglas,et al.  Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.

[52]  M. Foldvari,et al.  Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[53]  J W Eaton,et al.  Molecular basis of biomaterial-mediated foreign body reactions. , 2001, Blood.

[54]  Vladimir Parpura,et al.  Instrumentation: carbon nanotubes on the brain. , 2008, Nature nanotechnology.